Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling

[1]  D. Lieberman,et al.  Interleukin 6 as an energy allocator in muscle tissue , 2022, Nature Metabolism.

[2]  Youfa Wang,et al.  Health policy and public health implications of obesity in China. , 2021, The lancet. Diabetes & endocrinology.

[3]  L. Elo,et al.  Secretin activates brown fat and induces satiation , 2021, Nature Metabolism.

[4]  N. Djouder,et al.  Inhibition of the IL-17A axis in adipocytes suppresses diet-induced obesity and metabolic disorders in mice , 2021, Nature Metabolism.

[5]  L. Dahal,et al.  Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review , 2021, Frontiers in Immunology.

[6]  P. Arner,et al.  Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics , 2021, Nature Reviews Endocrinology.

[7]  T. Tosteson,et al.  Kynurenine‐Induced Aryl Hydrocarbon Receptor Signaling in Mice Causes Body Mass Gain, Liver Steatosis, and Hyperglycemia , 2021, Obesity.

[8]  D. Eizirik,et al.  Kdm2a deficiency in macrophages enhances thermogenesis to protect mice against HFD-induced obesity by enhancing H3K36me2 at the Pparg locus , 2021, Cell Death & Differentiation.

[9]  W. Xiong,et al.  Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis , 2021, Theranostics.

[10]  Ping Yang,et al.  MBD2 serves as a viable target against pulmonary fibrosis by inhibiting macrophage M2 program , 2020, Science Advances.

[11]  Cong‐Yi Wang,et al.  The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes , 2020, Frontiers in Immunology.

[12]  Fengguo Xu,et al.  Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage , 2020, Acta pharmaceutica Sinica. B.

[13]  N. Stefan.  Causes, consequences, and treatment of metabolically unhealthy fat distribution. , 2020, The lancet. Diabetes & endocrinology.

[14]  J. Rabinowitz,et al.  The small intestine shields the liver from fructose-induced steatosis , 2020, Nature Metabolism.

[15]  J. Sosman,et al.  Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies , 2020, Frontiers in Immunology.

[16]  J. Després,et al.  Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. , 2020, Circulation research.

[17]  Yue Sun,et al.  CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia. , 2020, Cell reports.

[18]  F. Mattivi,et al.  Tryptophan Metabolic Pathways Are Altered in Obesity and Are Associated With Systemic Inflammation , 2020, Frontiers in Immunology.

[19]  M. Blüher.  Metabolically Healthy Obesity , 2020, Endocrine reviews.

[20]  G. Shulman,et al.  Regulation of adipose tissue inflammation by interleukin 6 , 2020, Proceedings of the National Academy of Sciences.

[21]  L. Partridge,et al.  Branched-chain amino acids impact health and lifespan indirectly via amino acid balance and appetite control , 2019, Nature Metabolism.

[22]  E. Oikonomou,et al.  The role of adipose tissue in cardiovascular health and disease , 2018, Nature Reviews Cardiology.

[23]  S. Luquet,et al.  Genetic deficiency of indoleamine 2,3-dioxygenase promotes gut microbiota-mediated metabolic health , 2018, Nature Medicine.

[24]  W. Xiong,et al.  Simultaneous determination of tryptophan, kynurenine, kynurenic acid, xanthurenic acid and 5-hydroxytryptamine in human plasma by LC-MS/MS and its application to acute myocardial infarction monitoring. , 2018, Biomedical chromatography : BMC.

[25]  G. Lettre,et al.  Neuropilin-1 expression in adipose tissue macrophages protects against obesity and metabolic syndrome , 2018, Science Immunology.

[26]  T. Pereira,et al.  Kynurenic Acid and Gpr35 Regulate Adipose Tissue Energy Homeostasis and Inflammation. , 2018, Cell metabolism.

[27]  M. Zou,et al.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases , 2017, Cellular and Molecular Life Sciences.

[28]  R. Schwarcz,et al.  Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice. , 2016, Biochimica et biophysica acta.

[29]  D. Eizirik,et al.  Loss of Mbd2 Protects Mice Against High-Fat Diet–Induced Obesity and Insulin Resistance by Regulating the Homeostasis of Energy Storage and Expenditure , 2016, Diabetes.

[30]  Christian M. Metallo,et al.  Branched chain amino acid catabolism fuels adipocyte differentiation and lipogenesis , 2015, Nature chemical biology.

[31]  B. Balkau,et al.  The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation , 2015, Obesity.

[32]  P. Verhoest,et al.  Challenges and Opportunities in the Discovery of New Therapeutics Targeting the Kynurenine Pathway. , 2015, Journal of medicinal chemistry.

[33]  R. Baumgartner,et al.  Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice. , 2015, Cardiovascular research.

[34]  Ina Schuppe-Koistinen,et al.  Skeletal Muscle PGC-1α1 Modulates Kynurenine Metabolism and Mediates Resilience to Stress-Induced Depression , 2014, Cell.

[35]  G. Zaman,et al.  High-Throughput Fluorescence-Based Screening Assays for Tryptophan-Catabolizing Enzymes , 2014, Journal of biomolecular screening.

[36]  Hao Wang,et al.  The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells. , 2014, Cellular immunology.

[37]  D. Fuchs,et al.  Obesity‐related dysregulation of the Tryptophan–Kynurenine metabolism: Role of age and parameters of the metabolic syndrome , 2014, Obesity.

[38]  G. Oxenkrug,et al.  Kynurenines and vitamin B6: link between diabetes and depression. , 2013, Journal of bioinformatics and diabetes.

[39]  D. Munn,et al.  Indoleamine 2,3 dioxygenase and metabolic control of immune responses. , 2013, Trends in immunology.

[40]  P. Froguel,et al.  CALL FOR PAPERS Integrative and Translational Physiology: Inflammation and Immunity in Organ System Physiology Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone , 2012 .

[41]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[42]  Anthony E. Boitano,et al.  Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells , 2010, Science.

[43]  J. Stasch,et al.  Kynurenine is an endothelium-derived relaxing factor produced during inflammation , 2010, Nature Medicine.

[44]  C. Glass,et al.  Macrophages, inflammation, and insulin resistance. , 2010, Annual review of physiology.

[45]  D. Fairlie,et al.  Inflammatory lipid mediators in adipocyte function and obesity , 2010, Nature Reviews Endocrinology.

[46]  M. Czech,et al.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[47]  D. Fuchs,et al.  Chronic immune activation underlies morbid obesity: is IDO a key player? , 2007, Current drug metabolism.

[48]  Herbert Tilg,et al.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity , 2006, Nature Reviews Immunology.

[49]  D. Fuchs,et al.  Bariatric Surgery Cannot Prevent Tryptophan Depletion Due to Chronic Immune Activation in Morbidly Obese Patients , 2006, Obesity surgery.

[50]  E. Nexo,et al.  Determination of vitamin B6 vitamers and pyridoxic acid in plasma: development and evaluation of a high-performance liquid chromatographic assay. , 2002, Analytical biochemistry.

[51]  D. Ketelhuth,et al.  The role of the kynurenine pathway of tryptophan metabolism in cardiovascular disease , 2015, Hämostaseologie.

[52]  Hans-Georg Rammensee,et al.  IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism , 2008, Cancer Immunology, Immunotherapy.